Advertisement
U.S. markets open in 7 hours 37 minutes

Aptevo Therapeutics Inc. (APVO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.1557+0.0068 (+4.57%)
At close: 04:00PM EST
0.1599 +0.00 (+2.70%)
After hours: 08:00PM EST
Full screen
Loading interactive chart...
  • ACCESSWIRE

    Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update

    The Company's ALG.APV-527 Phase 1 Trial for the Treatment of Multiple Solid Tumors Continues to ProgressPlanning for APVO436 Phase 2 Trial Initiation in Both Relapsed/Refractory and Frontline AML OngoingExtended Cash Runway with $7 Million in Funding ...

  • ACCESSWIRE

    Aptevo to Present at Bio-Europe Conference

    SEATTLE, WA / ACCESSWIRE / November 1, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, ...

  • ACCESSWIRE

    Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business Update

    Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today reported financial results for the quarter ended June 30, 2023 and provided a business update, including duration of remission (DOR) data for its lead clinical candidate, APVO436.